Jeanne Féger

1.0k total citations
64 papers, 873 citations indexed

About

Jeanne Féger is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jeanne Féger has authored 64 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Jeanne Féger's work include Glycosylation and Glycoproteins Research (23 papers), Drug Transport and Resistance Mechanisms (14 papers) and Liver Disease Diagnosis and Treatment (14 papers). Jeanne Féger is often cited by papers focused on Glycosylation and Glycoproteins Research (23 papers), Drug Transport and Resistance Mechanisms (14 papers) and Liver Disease Diagnosis and Treatment (14 papers). Jeanne Féger collaborates with scholars based in France, Netherlands and Tunisia. Jeanne Féger's co-authors include J Agneray, Geneviève Durand, G Durand, Nathalie Séta, D. Biou, Elias Fattal, Patrick Couvreur, Rocío Fernández‐Urrusuno, Jean‐Denis Rouzeau and Phuong Nhi Bories and has published in prestigious journals such as Biomaterials, Hepatology and Analytical Biochemistry.

In The Last Decade

Jeanne Féger

63 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeanne Féger France 19 544 189 143 115 91 64 873
M K Bijsterbosch Netherlands 17 577 1.1× 220 1.2× 70 0.5× 87 0.8× 61 0.7× 27 1.1k
Shinsei Gasa Japan 21 754 1.4× 189 1.0× 69 0.5× 86 0.7× 170 1.9× 81 1.2k
Ming‐Yang Yeh Taiwan 18 427 0.8× 93 0.5× 94 0.7× 115 1.0× 31 0.3× 36 755
Franca Maria Tuccillo Italy 14 547 1.0× 214 1.1× 169 1.2× 172 1.5× 65 0.7× 36 963
Yong-Qiu Mao China 20 596 1.1× 205 1.1× 123 0.9× 213 1.9× 59 0.6× 50 1.1k
W C Kenney United States 16 451 0.8× 52 0.3× 57 0.4× 69 0.6× 133 1.5× 25 910
Zhi Jie Li Hong Kong 17 485 0.9× 103 0.5× 180 1.3× 159 1.4× 67 0.7× 27 824
Jerzy Grabarek Poland 19 492 0.9× 142 0.8× 101 0.7× 172 1.5× 62 0.7× 28 863
Shaohua Li China 16 453 0.8× 105 0.6× 124 0.9× 143 1.2× 161 1.8× 48 1.0k
Anna Stępczyńska Germany 7 769 1.4× 156 0.8× 116 0.8× 222 1.9× 52 0.6× 9 1.2k

Countries citing papers authored by Jeanne Féger

Since Specialization
Citations

This map shows the geographic impact of Jeanne Féger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanne Féger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanne Féger more than expected).

Fields of papers citing papers by Jeanne Féger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanne Féger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanne Féger. The network helps show where Jeanne Féger may publish in the future.

Co-authorship network of co-authors of Jeanne Féger

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanne Féger. A scholar is included among the top collaborators of Jeanne Féger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanne Féger. Jeanne Féger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández‐Urrusuno, Rocío, Elias Fattal, Jeanne Féger, Patrick Couvreur, & Patrice Thérond. (1997). Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials. 18(6). 511–517. 47 indexed citations
2.
Fernández‐Urrusuno, Rocío, Elias Fattal, Dominique Porquet, Jeanne Féger, & Patrick Couvreur. (1995). Evaluation of Liver Toxicological Effects Induced by Polyalkylcyanoacrylate Nanoparticles. Toxicology and Applied Pharmacology. 130(2). 272–279. 40 indexed citations
3.
Féger, Jeanne, et al.. (1992). Effect of monensin and diabetes on asialoglycoprotein degradation in rat hepatocytes. Cellular and Molecular Life Sciences. 48(8). 745–748. 1 indexed citations
4.
Porquet, Dominique, et al.. (1992). Evaluation of the hepatotoxicological effects of a drug in an in vivo/in vitro model. Cellular and Molecular Life Sciences. 48(3). 257–261. 4 indexed citations
5.
Séta, Nathalie, et al.. (1991). Asialoglycoprotein receptor in human isolated hepatocytes from normal liver and its apparent increase in liver with histological alterations. Journal of Hepatology. 13(3). 305–309. 36 indexed citations
6.
Séta, Nathalie, Bérangère Tissot, F Forestier, et al.. (1991). Changes in α1-acid glycoprotein serum concentrations and glycoforms in the developing human fetus. Clinica Chimica Acta. 203(2-3). 167–175. 19 indexed citations
7.
Lamaze, Christophe, et al.. (1991). Vasopressin‐induced changes in receptor‐mediated endocytosis of asialoglycoprotein in rat hepatocytes. Biology of the Cell. 73(1). 43–47. 1 indexed citations
8.
Appel, Martine, et al.. (1990). Effect of streptozotocin‐diabetes on rat liver asialoglycoprotein receptor turnover: in vivo degradation and in vitro biosynthesis. Biology of the Cell. 69(2). 107–111. 2 indexed citations
9.
Bories, Phuong Nhi, et al.. (1990). Prevalence of tri- and tetraantennary glycans of human? 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation. 14(3). 315–323. 66 indexed citations
10.
Bories, Phuong Nhi, et al.. (1990). A macrophage-derived factor induced by α1-acid glycoprotein that inhibits IL-1 comitogenic activity. Immunology Letters. 26(1). 105–110. 9 indexed citations
11.
Drechou, Anne, et al.. (1989). 抗体アフィニティークロマトグラフィーによるラット血しょうα 1 -酸糖蛋白質の一段精製 正常及び炎症を起こしたラット血清への適用. Journal of Chromatography A. 489(2). 273–281. 7 indexed citations
12.
Drechou, Anne, et al.. (1989). Increased affinity to concanavalin A and enhanced secretion of alpha 1-acid glycoprotein by hepatocytes isolated from turpentine-treated rats.. PubMed. 50(1). 111–6. 7 indexed citations
13.
Durand, G, et al.. (1989). Decreased number of asialoglycoprotein receptors in diabetic BB Wistar rat. Cellular and Molecular Life Sciences. 45(5). 480–482. 2 indexed citations
14.
Drechou, Anne, et al.. (1989). One-step purification of rat plasma α1-acid glycoprotein by antibody affinity chromatography: Application to normal and inflamed rat sera. Journal of Chromatography B Biomedical Sciences and Applications. 489(2). 273–281. 9 indexed citations
15.
Slama, Abdelhamid, et al.. (1988). Comparative determination of the asialoglycoprotein receptor by ligand and antibody binding in hepatocytes from normal and diabetic rats. Biology of the Cell. 63(3). 367–369. 9 indexed citations
16.
Séta, Nathalie, et al.. (1984). Evaluation of the degree of desialylation of serum C1-inactivator and haemopexin. Clinica Chimica Acta. 143(3). 235–241. 10 indexed citations
17.
Porquet, Dominique, et al.. (1984). Lipogenesis from U14C lactate in obese zucker rat hepatocytes. Effect of albumin-bound oleate.. Life Sciences. 35(11). 1213–1219. 1 indexed citations
18.
Durand, Geneviève, et al.. (1982). Comparative interaction of asialoorosomucoid and desialylated ovin submaxillary mucin with hepatocytes from normal and diabetic rats. FEBS Letters. 144(2). 345–348. 4 indexed citations
19.
Biou, D., Geneviève Durand, Jeanne Féger, & J Agneray. (1980). Incidence de divers facteurs sur le comportement immunochimique de l'α1-glycoproteine acide. Clinical Biochemistry. 13(1). 17–23. 1 indexed citations
20.
Durand, G, et al.. (1978). Colorimetric assay of sialic acid by a methyl-3-benzothiazolinone-2-hydrazone reactant. Analytical Biochemistry. 91(2). 618–625. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026